Eiger BioPharmaceuticals Strengthens Board of Directors with Addition of Industry Veteran Charles J. "Chuck" Bramlage
Mr. Bramlage is a pharmaceutical industry veteran with extensive experience in marketing, sales, and corporate operations spanning large pharma to start up pharma. He is currently the Chief Executive Officer of
"We enthusiastically welcome Chuck to our Board of Directors and look forward to benefiting from his background and experience as we begin to direct product development toward maximizing market opportunities for each pipeline program," said
Eiger is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare diseases. The company has built a diverse portfolio of well-characterized product candidates with the potential to address diseases for which the unmet medical need is high, the biology for treatment is clear, and for which an effective therapy is urgently needed.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/eiger-biopharmaceuticals-strengthens-board-of-directors-with-addition-of-industry-veteran-charles-j-chuck-bramlage-300245259.html